Anti-Hypertensive Drugs - Mauritius

Mauritius

The revenue in the Anti-Hypertensive Drugs market in Mauritius is estimated to reach US$1.57m in 2024.
It is expected to demonstrate a steady annual growth rate (CAGR 2024-2029) of 0.88%, leading to a market volume of US$1.64m by 2029.
When compared to other countries worldwide, United States is projected to generate the highest revenue, amounting to US$12,290.00m in 2024.
Mauritius has seen a rise in the demand for locally produced anti-hypertensive drugs due to increasing awareness about the importance of managing hypertension.

Key regions: Japan, India, Italy, Brazil, South Korea

Market

Region

Region comparison

Currency

Analyst Opinion

The Anti-Hypertensive Drugs market in Mauritius is a growing market with increasing demand for effective medication to treat hypertension.

Customer preferences: Mauritius has a high prevalence of hypertension, with a significant portion of the population suffering from the condition. As a result, there is a growing demand for effective anti-hypertensive drugs that can help manage the condition and reduce the risk of complications. Customers in Mauritius are increasingly seeking out medication that is both effective and affordable, as healthcare costs continue to rise.

Trends in the market: One of the key trends in the Anti-Hypertensive Drugs market in Mauritius is the increasing availability of generic medications. Generic drugs are becoming more widely available, as pharmaceutical companies seek to expand their market share in the country. This is leading to increased competition and lower prices for consumers, making it easier for patients to access the medication they need to manage their hypertension.Another trend in the market is the increasing use of combination therapies. Many patients in Mauritius require multiple medications to manage their hypertension effectively, and combination therapies can provide a more convenient and effective treatment option. This trend is likely to continue as more research is conducted on the effectiveness of different combinations of anti-hypertensive drugs.

Local special circumstances: One of the unique factors that influence the Anti-Hypertensive Drugs market in Mauritius is the country's aging population. As the population ages, the prevalence of hypertension is likely to increase, leading to a growing demand for anti-hypertensive drugs. Additionally, the high rates of obesity and diabetes in the country are also contributing to the increasing prevalence of hypertension, further driving demand for effective medication.

Underlying macroeconomic factors: The Anti-Hypertensive Drugs market in Mauritius is also influenced by broader macroeconomic factors. The country's growing middle class, for example, is becoming increasingly health-conscious and is willing to spend more on healthcare, including medication to manage hypertension. Additionally, the government's focus on improving healthcare access and outcomes is also driving demand for anti-hypertensive drugs. Overall, the Anti-Hypertensive Drugs market in Mauritius is likely to continue to grow as the population ages, healthcare costs rise, and demand for effective medication increases.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.